- Home
- GERN vs ARCH Comparison
GERN vs ARCH Comparison
Compare GERN & ARCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GERN
- ARCH
- Stock Information
- Founded
- GERN 1990
- ARCH 1969
- Country
- GERN United States
- ARCH United States
- Employees
- GERN N/A
- ARCH N/A
- Industry
- GERN Biotechnology: Pharmaceutical Preparations
- ARCH Coal Mining
- Sector
- GERN Health Care
- ARCH Energy
- Exchange
- GERN Nasdaq
- ARCH Nasdaq
- Market Cap
- GERN 2.5B
- ARCH 2.6B
- IPO Year
- GERN 1996
- ARCH 1988
- Fundamental
- Price
- GERN $3.66
- ARCH $164.06
- Analyst Decision
- GERN Strong Buy
- ARCH Buy
- Analyst Count
- GERN 10
- ARCH 5
- Target Price
- GERN $6.95
- ARCH $173.60
- AVG Volume (30 Days)
- GERN 9.5M
- ARCH 385.9K
- Earning Date
- GERN 11-07-2024
- ARCH 11-05-2024
- Dividend Yield
- GERN N/A
- ARCH 0.83%
- EPS Growth
- GERN N/A
- ARCH N/A
- EPS
- GERN N/A
- ARCH 9.67
- Revenue
- GERN $29,480,000.00
- ARCH $2,645,357,000.00
- Revenue This Year
- GERN $30,930.80
- ARCH N/A
- Revenue Next Year
- GERN $315.72
- ARCH N/A
- P/E Ratio
- GERN N/A
- ARCH $16.98
- Revenue Growth
- GERN 9199.68
- ARCH N/A
- 52 Week Low
- GERN $1.64
- ARCH $116.44
- 52 Week High
- GERN $5.34
- ARCH $187.60
- Technical
- Relative Strength Index (RSI)
- GERN 29.99
- ARCH 67.09
- Support Level
- GERN $3.98
- ARCH $161.08
- Resistance Level
- GERN $4.50
- ARCH $171.87
- Average True Range (ATR)
- GERN 0.21
- ARCH 5.51
- MACD
- GERN -0.05
- ARCH 0.95
- Stochastic Oscillator
- GERN 3.45
- ARCH 77.43
About GERN Geron Corporation
Geron Corp is a clinical-stage biopharmaceutical company focused on the research and development of cancer treatments. The company's drug in development, Imelstat, is being tested for the treatment of myelodysplastic syndromes, which are disorders of the blood, and myelofibrosis, which is a rare blood cancer affecting bone marrow. The company earns revenue through collaboration agreements, milestones, royalties, and licensing arrangements. Geron possesses various rights to this drug. The company operates as a single segment being, the development of therapeutic products for oncology.
About ARCH Arch Resources Inc.
Arch Resources Inc is a producer of metallurgical and coking coal. The company sells its coal to power plants, steel mills, and industrial facilities. Its operating segment includes Metallurgical (MET) and Thermal. It generates maximum revenue from the Metallurgical (MET) segment. Geographically, it derives a majority of its revenue from Asia.